LncRNA FOXD1-AS1 acts as a potential oncogenic biomarker in glioma.
Yuan-Feng GaoJun-Yan LiuXiao-Yuan MaoZheng-Wen HeTao ZhuZhi-Bin WangXi LiJi-Ye YinWei ZhangHong-Hao ZhouZhao-Qian LiuPublished in: CNS neuroscience & therapeutics (2019)
These data indicated that FOXD1-AS1, a miR339/342 target, affected biological processes via protein eIF5a; thus, it might be considered as a new therapeutic target for glioblastoma.